login
  Password reminder

Subscribe Edit your account | View your account

Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 




Featured Highlights
41 - 60 of 135   Items
Benefits of computed tomography outweigh cancer risks in young adults

Benefits of computed tomography outweigh cancer risks in young adults

Thursday, 21 Feb 2013
A study, jointly led by Robert L Zondervan and Susanna Lee, has said that young adults who undergo computed tomography (CT) are more at risk from underlying medical conditions rather than radiation-induced cancer from CT. Benefits of computed tomography outweigh cancer risks in young adults
Varian Medical Systems receives FDA 510(k) clearance for the Edge radiosurgery suite

Varian Medical Systems receives FDA 510(k) clearance for the Edge radiosurgery suite

Wednesday, 30 Jan 2013
Edge radiosurgery suite, a new dedicated system for performing advanced radiosurgery using real-time tumour tracking and motion management technologies, has been granted FDA approval. Varian Medical Systems receives FDA 510(k) clearance for the Edge radiosurgery suite
Interventional treatment with radioactive beads could help colon cancer patients live longer

Interventional treatment with radioactive beads could help colon cancer patients live longer

Monday, 28 Jan 2013
In a presentation at ISET, data from a study using Y-90 radioactive beads for the treatment of liver-dominant metastases from colorectal cancer showed that patients may live longer than with chemotherapy alone. Interventional treatment with radioactive beads could help colon cancer patients live longer
Upgraded version of Accu2i pMTA microwave ablation device gets FDA clearance

Upgraded version of Accu2i pMTA microwave ablation device gets FDA clearance

Tuesday, 11 Dec 2012
Improvements of the new device include a refined optically clear moulded handle and improved connection cartridge. Upgraded version of Accu2i pMTA microwave ablation device gets FDA clearance
FDA clears FlightPlan for Liver imaging tool for liver embolization procedures

FDA clears FlightPlan for Liver imaging tool for liver embolization procedures

Monday, 26 Nov 2012
The FlightPlan for Liver tool (GE Healthcare), developed by physicians and engineers, helps interventionalists plan their liver embolization procedures in a simpler manner. FDA clears FlightPlan for Liver imaging tool for liver embolization procedures
CyberKnife VSI System now in India

CyberKnife VSI System now in India

Thursday, 22 Nov 2012
Accuray Incorporated has announced that Medanta – The Medicity Cancer Institute, and the Roentgen-BLK Super Speciality Hospital both recently acquired and started treating patients with the CyberKnife VSI System, marking it the first-in-country CyberKnife VSI System in India. CyberKnife VSI System now in India
Thermedical receives FDA 510(k) clearance for new ablation system

Thermedical receives FDA 510(k) clearance for new ablation system

Wednesday, 07 Nov 2012
The new system, sponsored by the Massachussets Life Sciences Centre, utilises radiofrequency for the treatment of large tumours, including liver cancer. Thermedical receives FDA 510(k) clearance for new ablation system
Delcath receives regulatory approval for the Generation Two Hepatic Chemosat Delivery system in Australia

Delcath receives regulatory approval for the Generation Two Hepatic Chemosat Delivery system in Australia

Tuesday, 06 Nov 2012
The approval allows Delcath to market and sell the system used to treat unresectable metastatic melanoma in the liver in Australia. Delcath receives regulatory approval for the Generation Two Hepatic Chemosat Delivery system in Australia
Sirtex Medical launches SIR-Spheres microspheres in Latin America

Sirtex Medical launches SIR-Spheres microspheres in Latin America

Monday, 15 Oct 2012
The first treatment with the SIR-Spheres Microspheres for inoperable liver tumours was carried out at Hospital Italiano de Buenos Aires in Argentina. Sirtex Medical launches SIR-Spheres microspheres in Latin America

FDA clears Surefire Medical Angiographic Catheters

Monday, 15 Oct 2012
According to a company release, the Surefire Angiographic Catheters are designed to provide interventional radiologists with greater flexibility and a high level of trackability when performing infusion procedures. FDA clears Surefire Medical Angiographic Catheters

Philips and Biocompatibles team-up to advance image guided transarterial embolizations in interventional oncology

Wednesday, 19 Sep 2012
At CIRSE 2012, Philips and Biocompatibles announced a collaboration to advance the use of image guidance to control the delivery of beads during the arterial embolization of hypervascularised tumours. Philips and Biocompatibles team-up to advance image guided transarterial embolizations in interventional oncology
Is there a difference in radioembolization outcomes between glass and resin microspheres?

Is there a difference in radioembolization outcomes between glass and resin microspheres?

Thursday, 06 Sep 2012
Is one device more effective than the other, with respect to radioembolization for hepatocellular carcinoma with or without portal vein thrombosis, metastatic colorectal cancer and neuroendocrine tumours? Examining the medical literature, the answer is “no”, Robert Lewandowski, Chicago, USA, said. Is there a difference in radioembolization outcomes between glass and resin microspheres?
Surefire Infusion System for embolization procedures receives CE mark approval

Surefire Infusion System for embolization procedures receives CE mark approval

Wednesday, 05 Sep 2012
In a retrospective study of 29 patients, infusion of therapeutic agent with the Surefire Infusion System showed no angiographic evidence of reflux and no clinical evidence of non-target embolization. Surefire Infusion System for embolization procedures receives CE mark approval

UK’s NICE publishes guidance for ultrasound testing to diagnose liver cancer

Thursday, 30 Aug 2012
The guidance recommends the use of SonoVue (Bracco) in adults to investigate lesions to the liver that is detected incidentally, but not characterised, on an unenhanced ultrasound scan. UK’s NICE publishes guidance for ultrasound testing to diagnose liver cancer

Delcath submits new drug application for its chemosaturation system to FDA

Friday, 17 Aug 2012
The new drug application seeks approval of Delcath’s chemosaturation system for use with melphalan hydrochloride in the treatment of patients with unresectable metastatic melanoma in the liver. Delcath submits new drug application for its chemosaturation system to FDA
Surefire Medical receives FDA clearance for High-Flow Microcatheter

Surefire Medical receives FDA clearance for High-Flow Microcatheter

Monday, 09 Jul 2012
The Surefire system is designed to deliver therapy with higher infusion efficiency than conventional microcatheters to treat primary and secondary liver cancer. Surefire Medical receives FDA clearance for High-Flow Microcatheter
The difference between technician and oncologist will take interventional oncology where it should be

The difference between technician and oncologist will take interventional oncology where it should be

Friday, 06 Jul 2012
Radiation oncologist, Lizbeth Kenny, Queensland, Australia, told interventional oncologists, at the ECIO meeting (25–28 April, Florence, Italy), that if they want to be accepted as real clinicians in the field of cancer care, focusing on being excellent technicians is not enough. She will be talking on this topic at CIRSE 2012. The difference between technician and oncologist will take interventional oncology where it should be
“Both interventional radiologists and radiation oncologists would benefit from an alliance”

“Both interventional radiologists and radiation oncologists would benefit from an alliance”

Thursday, 05 Jul 2012
Andy Adam, London, UK, proposed during his Honorary Lecture at ECIO, that an alliance with radiation oncology would benefit both interventional radiologists and radiation oncologists: “the radiation oncologists would gain a ‘surgical arm’ to their armamentarium and the interventional radiologists would gain access to the infrastructure and resident medical staff that they need to look after their own patients.” he said. “Both interventional radiologists and radiation oncologists would benefit from an alliance”
NanoKnife System safe to treat liver tumors adjacent to blood vessels

NanoKnife System safe to treat liver tumors adjacent to blood vessels

Wednesday, 04 Jul 2012
At an average follow-up of six months, 96% of patients were without persistent disease and 95% of tumors had not recurred locally. NanoKnife System safe to treat liver tumors adjacent to blood vessels

Delcath to offer second generation haemofiltration cartridge in US expanded access programme

Monday, 02 Jul 2012
Delcath Systems has announced that the company has amended its investigational new drug application and its expanded access programme to include the use of the second-generation haemofiltration cartridge of the company’s proprietary chemosaturation system. Delcath to offer second generation haemofiltration cartridge in US expanded access programme
Found: 135   Displaying: 41-60
Results: 3 4 5 6 7 Next Go to:
Related Section
Clinical Trials
Interventional Oncology News
Interventional Oncology Supplement
Key Opinion Leaders discuss the role of Biocompatible's DC Bead at CIRSE and ILCA
IR Views
Literature
Oncology Useful Links

Related Feeds

Latest News




Monday, 31 Mar 2014

Features





Profiles





Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions